Nubeqa is an androgen receptor inhibitor indicated for the treatment of
patients with non-metastatic castration-resistant prostate cancer.
Nubeqa (darolutamide) a prescription medicine used to treat prostate cancer that has not spread to other parts of your body. Nubeqa is given after surgery or other treatments did not work or have stopped working. It is not known if Nubeqa is safe and effective in children or in females.
Darolutamide, sold under the brand name Nubeqa, is an antiandrogen medication which is used in the treatment of non-metastatic castration-resistant prostate cancer in men. It is specifically approved to treat non-metastatic castration-resistant prostate cancer (nmCRPC) in conjunction with surgical or medical castration. The medication is taken by mouth twice per day with food.Darolutamide was patented in 2011, and was approved for medical use in July 2019.
Darolutamide is used to treat a certain type of prostate cancer. This medication belongs to a class of drugs known as anti-androgens (anti-testosterone). It works by blocking the effects of testosterone to slow the growth and spread of prostate cancer.
For procurement cost of Nubeqa (darolutamide)) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.
Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA.
For Indian Patients Nubeqa (darolutamide)) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India.
For overseas patient Nubeqa (darolutamide)) brand in India can be also made available to overseas patients, doctors and hospitals. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.